Formulation Development White Papers & Articles
-
Biocatalysis 101: Faster, Greener API Manufacturing
4/20/2026
View how enzyme-driven reactions accelerate pharmaceutical ingredient manufacturing, improve selectivity, reduce waste, lower costs, and support scalable, sustainable processes under mild conditions.
-
ADC Development Grows More Complex — SPR Insights Bring Clarity
4/14/2026
Explore how real-time kinetic analysis reveals how conjugation, linker chemistry, and drug loading influence antibody–antigen interactions, while enabling sensitive detection of anti-drug antibodies.
-
High Potency APIs And The Evolving Demands Of Drug Development
4/13/2026
See how higher API activity is changing expectations around containment, scalability, and cross‑functional alignment — and why early decisions now have a greater impact on long‑term success.
-
Targeted Modalities Set Elevated Standards For Precision
4/7/2026
Explore how targeted modalities like ADCs and TPDs are transforming precision medicine, unlocking new treatment opportunities, and overcoming development challenges to improve patient outcomes.
-
The Top Tech Transfer Risks At Multi-Site CDMOs
3/31/2026
Many tech transfer risks are avoidable with a single campus CDMO. With all manufacturing facilities on one site, drug sponsors can overcome obstacles and maintain speed en route to market.
-
Color Consistency In UHMWPE Medical Textiles
3/26/2026
Color consistency improves surgical visibility, differentiation, and workflow efficiency, requiring medical textiles that deliver strength, compliance, and reliable quality in every color.
-
Improving Next-Generation Sequencing Workflows With Droplet Digital PCR
3/25/2026
Optimize NGS workflows by using digital PCR for absolute quantification. Improve library quality, reduce bias, and gain sensitive validation for rare variants in complex genomic samples.
-
Rethinking Design, Cost, And Scalability In Biomanufacturing
3/24/2026
Life science teams increasingly need tools that scale, simplify workflows, and reduce operational costs. Examine how emerging instrumentation focuses on usability, performance, and manufacturability.
-
Navigating Preclinical Drug Development Challenges With Lipid-Based Formulations
3/20/2026
Maximize the oral bioavailability of challenging small-molecule candidates and streamline the path from preclinical toxicology to clinical trials by leveraging optimized lipid-based formulations.
-
Quantifying Endotoxins Via Absorbance Or Fluorescence
3/20/2026
Find out how endotoxin assays use Factor C activation to generate measurable absorbance or fluorescence signals, with guidance on selecting detection formats and implementing scalable workflows.